164 related articles for article (PubMed ID: 9124827)
21. Regulation of syringomycin synthesis in Pseudomonas syringae pv. syringae and defined conditions for its production.
Gross DC
J Appl Bacteriol; 1985 Feb; 58(2):167-74. PubMed ID: 3980301
[TBL] [Abstract][Full Text] [Related]
22. Change in activity of serine palmitoyltransferase affects sensitivity to syringomycin E in yeast Saccharomyces cerevisiae.
Toume M; Tani M
FEMS Microbiol Lett; 2014 Sep; 358(1):64-71. PubMed ID: 25040056
[TBL] [Abstract][Full Text] [Related]
23. Structure of syringotoxin, a bioactive metabolite of Pseudomonas syringae pv. syringae.
Ballio A; Bossa F; Collina A; Gallo M; Iacobellis NS; Paci M; Pucci P; Scaloni A; Segre A; Simmaco M
FEBS Lett; 1990 Sep; 269(2):377-80. PubMed ID: 2401362
[TBL] [Abstract][Full Text] [Related]
24. Arborcandins A, B, C, D, E and F, novel 1,3-beta-glucan synthase inhibitors: production and biological activity.
Ohyama T; Kurihara Y; Ono Y; Ishikawa T; Miyakoshi S; Hamano K; Arai M; Suzuki T; Igari H; Suzuki Y; Inukai M
J Antibiot (Tokyo); 2000 Oct; 53(10):1108-16. PubMed ID: 11132955
[TBL] [Abstract][Full Text] [Related]
25. In vitro studies of aculeacin A, a new antifungal antibiotic.
Iwata K; Yamamoto Y; Yamaguchi H; Hiratani T
J Antibiot (Tokyo); 1982 Feb; 35(2):203-9. PubMed ID: 7042670
[TBL] [Abstract][Full Text] [Related]
26. Ecomycins, unique antimycotics from Pseudomonas viridiflava.
Miller CM; Miller RV; Garton-Kenny D; Redgrave B; Sears J; Condron MM; Teplow DB; Strobel GA
J Appl Microbiol; 1998 Jun; 84(6):937-44. PubMed ID: 9717277
[TBL] [Abstract][Full Text] [Related]
27. Pseudomonas lipodepsipeptides and fungal cell wall-degrading enzymes act synergistically in biological control.
Fogliano V; Ballio A; Gallo M; Woo S; Scala F; Lorito M
Mol Plant Microbe Interact; 2002 Apr; 15(4):323-33. PubMed ID: 12026170
[TBL] [Abstract][Full Text] [Related]
28. An In Vitro Attempt for Controlling Severe Phytopathogens and Human Pathogens Using Essential Oils from Mediterranean Plants of Genus Schinus.
Elshafie HS; Ghanney N; Mang SM; Ferchichi A; Camele I
J Med Food; 2016 Mar; 19(3):266-73. PubMed ID: 26836214
[TBL] [Abstract][Full Text] [Related]
29. Biological activities of pseudomycin A, a lipodepsinonapeptide from Pseudomonas syringae MSU 16H.
Di Giorgio D; Camoni L; Marchiafava C; Ballio A
Phytochemistry; 1997 Aug; 45(7):1385-91. PubMed ID: 9237401
[TBL] [Abstract][Full Text] [Related]
30. The in-vitro activity of an antifungal antibiotic benanomicin A in comparison with amphotericin B.
Watanabe M; Hiratani T; Uchida K; Ohtsuka K; Watabe H; Inouye S; Kondo S; Takeuchi T; Yamaguchi H
J Antimicrob Chemother; 1996 Dec; 38(6):1073-7. PubMed ID: 9023656
[TBL] [Abstract][Full Text] [Related]
31. Genetic organization and regulation of proteins associated with production of syringotoxin by Pseudomonas syringae pv. syringae.
Morgan MK; Chatterjee AK
J Bacteriol; 1988 Dec; 170(12):5689-97. PubMed ID: 2848011
[TBL] [Abstract][Full Text] [Related]
32. Toxin production by pathovars of Pseudomonas syringae and their antagonistic activities against epiphytic microorganisms.
Völksch B; Weingart H
J Basic Microbiol; 1998; 38(2):135-45. PubMed ID: 9637014
[TBL] [Abstract][Full Text] [Related]
33. Lipopeptide phytotoxins produced by Pseudomonas syringae pv. syringae: comparison of the biosurfactant and ion channel-forming activities of syringopeptin and syringomycin.
Hutchison ML; Gross DC
Mol Plant Microbe Interact; 1997 Apr; 10(3):347-54. PubMed ID: 9100379
[TBL] [Abstract][Full Text] [Related]
34. Structure and dynamics of the antifungal molecules Syringotoxin-B and Syringopeptin-25A from molecular dynamics simulation.
Mátyus E; Blaskó K; Fidy J; Tieleman DP
Eur Biophys J; 2008 Apr; 37(4):495-502. PubMed ID: 18064450
[TBL] [Abstract][Full Text] [Related]
35. Isolation of cepafungins I, II and III from Pseudomonas species.
Shoji J; Hinoo H; Kato T; Hattori T; Hirooka K; Tawara K; Shiratori O; Terui Y
J Antibiot (Tokyo); 1990 Jul; 43(7):783-7. PubMed ID: 2387772
[TBL] [Abstract][Full Text] [Related]
36. Antibacterial and antifungal activity of cicerfuran and related 2-arylbenzofurans and stilbenes.
Aslam SN; Stevenson PC; Kokubun T; Hall DR
Microbiol Res; 2009; 164(2):191-5. PubMed ID: 17418552
[TBL] [Abstract][Full Text] [Related]
37. Saprophytic Pseudomonas syringae strain M1 of wheat produces cyclic lipodepsipeptides.
Adetuyi FC; Isogai A; Di Giorgio D; Ballio A; Takemoto JY
FEMS Microbiol Lett; 1995 Aug; 131(1):63-7. PubMed ID: 7557311
[TBL] [Abstract][Full Text] [Related]
38. In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds.
Del Poeta M; Schell WA; Perfect JR
Antimicrob Agents Chemother; 1997 Aug; 41(8):1835-6. PubMed ID: 9257774
[TBL] [Abstract][Full Text] [Related]
39. L-671,329, a new antifungal agent. III. In vitro activity, toxicity and efficacy in comparison to aculeacin.
Fromtling RA; Abruzzo GK
J Antibiot (Tokyo); 1989 Feb; 42(2):174-8. PubMed ID: 2647704
[TBL] [Abstract][Full Text] [Related]
40. Laboratory evaluation of new antifungal agents against rare and refractory mycoses.
Sutton DA
Curr Opin Infect Dis; 2002 Dec; 15(6):575-82. PubMed ID: 12821833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
